Dechra Pharmaceuticals Holdings Limited is a global pharmaceutical company specializing in animal health. Founded in 2023, Dechra focuses on the research, development, manufacturing, and marketing of veterinary pharmaceuticals. The company operates as a limited company, registered with the UK’s Financial Conduct Authority (FCA) under the registration number 14856770. Dechra’s core business centers around the development and production of a diverse range of products including analgesics, anti-inflammatories, antibiotics, and nutritional supplements for companion animals and livestock. They provide solutions for a wide variety of animal species, including dogs, cats, horses, cattle, and poultry. The company’s international presence is significant, with a growing network of subsidiaries and partners across Europe, North America, and Asia. Dechra is actively expanding its global footprint through strategic partnerships and acquisitions. As a limited company, Dechra employs a dedicated team of professionals, with a focus on innovation and quality within the animal health sector. The company’s size is estimated to be mid-sized, with a key focus on specialized veterinary treatments. The company’s SIC codes include: - 64209: Activities of other holding companies n.e.c.

Dechra Pharmaceuticals Holdings Limited is a global pharmaceutical company specializing in animal health. Founded in 2023, Dechra focuses on the research, development, manufacturing, and marketing of veterinary pharmaceuticals. The company operates as a limited company, registered with the UK’s Financial Conduct Authority (FCA) under the registration number 14856770. Dechra’s core business centers around the development and production of a diverse range of products including analgesics, anti-inflammatories, antibiotics, and nutritional supplements for companion animals and livestock. They provide solutions for a wide variety of animal species, including dogs, cats, horses, cattle, and poultry. The company’s international presence is significant, with a growing network of subsidiaries and partners across Europe, North America, and Asia. Dechra is actively expanding its global footprint through strategic partnerships and acquisitions. As a limited company, Dechra employs a dedicated team of professionals, with a focus on innovation and quality within the animal health sector. The company’s size is estimated to be mid-sized, with a key focus on specialized veterinary treatments. The company’s SIC codes include: - 64209: Activities of other holding companies n.e.c.